Physician
Pediatric Choice LLC
Pediatric Choice LLC was paid $13.12M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoPEDIATRIC CHOICE LLC
LENOIR CITY, TN 37772
LENOIR CITY, TN 37772
33aNPI1811023989assigned 02/26/2007
33bProvider typePediatrics Physician
28Total paid$13.12M
24GClaims375,977
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#6 of 333
Median peer was paid$139K
This provider vs. median94×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 51,398 | $1.65M | |
| 2019 | 55,848 | $1.83M | |
| 2020 | 43,904 | $1.52M | |
| 2021 | 50,173 | $1.76M | |
| 2022 | 53,368 | $1.91M | |
| 2023 | 64,594 | $2.31M | |
| 2024incomplete | 56,692 | $2.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 89,937 | 80,979 | $4.51M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.5% | 25,934 | 23,772 | $1.25M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.5% | 13,693 | 12,826 | $1.12M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.3% | 11,679 | 10,975 | $953K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5.9% | 33,921 | 31,690 | $778K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.8% | 10,239 | 9,752 | $760K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.4% | 22,350 | 20,630 | $703K |
| 92552 | 4.6% | 27,522 | 25,428 | $600K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.0% | 5,889 | 5,328 | $526K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.1% | 13,531 | 12,036 | $409K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.1% | 5,545 | 4,854 | $408K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.1% | 3,765 | 3,454 | $282K |
62 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 5,224 | $252K |
| 99177 | <1% | 25,554 | $89K | |
| 87428 | <1% | 1,027 | $63K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,711 | $59K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,301 | $48K |
| 96127 | <1% | 8,590 | $40K | |
| 96160 | <1% | 8,362 | $38K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,157 | $34K |
| 99381 | <1% | 386 | $32K | |
| 92015 | Determination of refractive state | <1% | 838 | $20K |
| 83655 | <1% | 1,339 | $15K | |
| 87807 | <1% | 1,339 | $13K | |
| 99383 | <1% | 125 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 675 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 463 | $8K |
| 97802 | <1% | 518 | $7K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 438 | $7K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 116 | $7K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 173 | $7K |
| 85018 | <1% | 2,963 | $7K | |
| 90670 | <1% | 7,108 | $7K | |
| 3008F | <1% | 642 | $6K | |
| 99382 | <1% | 72 | $6K | |
| 36416 | <1% | 4,206 | $6K | |
| 99384 | <1% | 40 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 231 | $4K |
| 94760 | <1% | 5,847 | $3K | |
| 90651 | <1% | 904 | $2K | |
| 90710 | <1% | 438 | $2K | |
| 81003 | <1% | 980 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 59 | $2K |
| 90723 | <1% | 4,737 | $1K | |
| 90677 | <1% | 971 | $1K | |
| 90686 | <1% | 4,461 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 15 | $1K |
| 90633 | <1% | 2,480 | $1K | |
| 90716 | <1% | 481 | $953.44 | |
| 90681 | <1% | 1,035 | $812.80 | |
| 90696 | <1% | 278 | $669.37 | |
| 90707 | <1% | 528 | $584.79 | |
| 90647 | <1% | 4,289 | $575.32 | |
| 90734 | <1% | 387 | $394.41 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 60 | $378.27 |
| 90473 | <1% | 16 | $308.81 | |
| 90697 | <1% | 150 | $252.00 | |
| 90672 | <1% | 181 | $176.65 | |
| 80061 | Lipid panel | <1% | 13 | $165.37 |
| 90715 | <1% | 351 | $165.21 | |
| 90661 | <1% | 27 | $70.00 | |
| 86308 | <1% | 14 | $62.93 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18 | $33.35 |
| 90674 | <1% | 87 | $28.44 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 233 | $10.62 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $4.98 |
| 90657 | 0% | 73 | $0.00 | |
| 90619 | 0% | 479 | $0.00 | |
| 90680 | 0% | 30 | $0.00 | |
| 90649 | 0% | 38 | $0.00 | |
| 90671 | 0% | 368 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 93 | $0.00 |
| 90700 | 0% | 54 | $0.00 | |
| 90685 | 0% | 186 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMER, SYED (OWNER)